Toxicity and quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy

Annals of Surgical Oncology

Volumn 13, Issue 12, 2006, Pages 1627-1632

  Tuttle, Todd M ^a   Zhang, Yan ^b   Greeno, Edward ^c   Knutsen, Amy ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cytoreductive surgery; Hyperthermia; Intraperitoneal chemotherapy; Peritoneal metastases; Quality of life

Indexed keywords

MITOMYCIN C;

ABDOMINAL ABSCESS; ABDOMINAL PAIN; ADULT; ARTICLE; ASCITES; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURVIVAL; CANCER THERAPY; CELLULITIS; CHEMOTHERAPY; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; DEEP VEIN THROMBOSIS; DIGESTIVE SYSTEM FISTULA; FEMALE; FUNCTIONAL ASSESSMENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERTHERMIC THERAPY; LUNG EMBOLISM; MALE; MORTALITY; NAUSEA; PANCREATITIS; PERITONEAL CAVITY; PERITONEUM METASTASIS; PERITONEUM TUMOR; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; QUALITY OF LIFE; SMALL INTESTINE OBSTRUCTION; SURVIVAL RATE; SURVIVAL TIME; TOXICITY; URINARY TRACT INFECTION;

ANTIBIOTICS, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; FEMALE; HOSPITALIZATION; HUMANS; HYPERTHERMIA, INDUCED; LENGTH OF STAY; MALE; MIDDLE AGED; MITOMYCIN; PERITONEAL CAVITY; PERITONEAL NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVIVAL RATE;

EID: 33845641010     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9186-6     Document Type: Article

References (25)

1. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999; 6:727-31.
2. Glehen O, Schreiber V, Cotte E, et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 2004; 139:20-6.
3. Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multiinstitutional study. J Clin Oncol 2004; 22:3284-92.
4. Feldman AL, Libutti SK, Pingpank JF, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 2003; 21:4560-7.
5. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21:3737-43.
6. Shen P, Hawksworth J, Lovato J, Loggie BW, Geisinger KR, Fleming RA, Levine EA. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 2004; 11:178-86.
7. Ahmad SA, Kim J, Sussman JJ, Soldano DA, Pennington LJ, James LE, Lowy AM. Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion. Ann Surg Oncol 2004; 11:387-92.
8. Yonemura Y, Kawamura T, Bandou E, Takahashi S, Sawa T, Matsuki N. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 2005; 92:370-5.
9. Verwaal VJ, van Tinteren H, Ruth SV, Zoetmulder FA. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 2004; 85:61-7.
10. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221:29-42.
11. Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11:570-9.
12. Tukey JW. Components in regression. Biometrics 1951; 7:33-69.
13. Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies-results of the EVOCAPE1 Multicentric Prospective Study. Cancer 2000; 88:358-63.
14. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999; 6:790-6.
15. Zoetmulder FA, Verwaal V, Ruth S. Hyperthermic intraperitoneal chemotherapy (HIPEC) with mitomycin C significantly improves survival in patients with peritoneal carcinomatosis of colorectal origin. Am Soc Clin Oncol 2002; 21:228; ; [Abstract 586].
16. Smeenk RM, Verwaal VJ, Zoetmulder FA. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei - a report of 103 procedures. Eur J Surg Oncol 2006; 32:186-90.
17. Younan R, Kusamura S, Baratti D, et al. Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closedtechnique intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2005; 12:910-8.
18. Glehen O, Osinsky D, Cotte E, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 2003; 10:863-9.
19. Jacquet P, Stephens AD, Averbach A, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 1996; 77:2622-9.
20. Jacquet P, Averbach A, Stephens AD, Stuart OA, Chang D, Sugarbaker PH. Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies. Oncology 1998; 55:130-8.
21. Elias D, Sideris L, Pocard M, et al. Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients. Ann Oncol 2004; 15:781-5.
22. McQuellon RP, Loggie BW, Fleming RA, Russell GB, Lehman AB, Rambo TD. Quality of life after intraperitoneal hyperthermic chemotherapy (IHPC) for peritoneal carcinomatosis. Eur J Surg Oncol 2001; 27:65-73.
23. McQuellon RP, Loggie BW, Lehman AB, Russell GB, Fleming RA, Shen P, Levine EA. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 2003; 10:155-62.
24. Yoo HJ, Kim JC, Eremenco S, Han OS. Quality of life in colorectal cancer patients with colectomy and the validation of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C), Version 4. J Pain Symptom Manage 2005; 30:24-32.
25. Anthony T, Long J, Hynan LS, et al. Surgical complications exert a lasting effect on disease-specific health-related quality of life for patients with colorectal cancer. Surgery 2003; 134:119-25.